{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:28:56Z","timestamp":1772814536630,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/ftd.0b013e3182a3ab42","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T13:52:35Z","timestamp":1379771555000},"page":"252-256","source":"Crossref","is-referenced-by-count":9,"title":["Detection of 4 Benzodiazepines in Oral Fluid as Biomarker for Presence in Blood"],"prefix":"10.1097","volume":"36","author":[{"given":"Hallvard","family":"Gjerde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaarina","family":"Langel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donata","family":"Favretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain G.","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210129","first-page":"2","article-title":". Analysis of drugs of abuse in saliva.","volume":"11","author":"Samyn","year":"1999","journal-title":"Forensic Sci Rev"},{"key":"R2-17-20210129","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1515\/CCLM.2004.248","article-title":"Oral fluid as a diagnostic tool.","volume":"42","author":"Choo","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R3-17-20210129","first-page":"147","article-title":"Drug testing in oral fluid.","volume":"27","author":"Drummer","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1373\/clinchem.2008.108670","article-title":"Oral fluid testing for drugs of abuse.","volume":"55","author":"Bosker","year":"2009","journal-title":"Clin Chem"},{"key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jat\/17.6.338","article-title":". Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions.","volume":"17","author":"Kato","year":"1993","journal-title":"J Anal Toxicol"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1373\/49.1.121","article-title":". Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.","volume":"49","author":"Schepers","year":"2003","journal-title":"Clin Chem"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jat\/24.7.536","article-title":". The effects of collection methods on oral fluid codeine concentrations.","volume":"24","author":"ONeal","year":"2000","journal-title":"J Anal Toxicol"},{"key":"R8-17-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","article-title":"Oral fluid collection: the neglected variable in oral fluid testing.","volume":"150","author":"Crouch","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.forsciint.2012.09.017","article-title":". Repeatability of oral fluid collection methods for THC measurement.","volume":"223","author":"Houwing","year":"2012","journal-title":"Forensic Sci Int"},{"key":"R10-17-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181ae46ea","article-title":". Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of DUID.","volume":"31","author":"Wille","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R11-17-20210129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jat\/34.4.204","article-title":". Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device.","volume":"34","author":"Gjerde","year":"2010","journal-title":"J Anal Toxicol"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva.","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R16-17-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2012.01.001","article-title":". Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.","volume":"219","author":"Vindenes","year":"2012","journal-title":"Forensic Sci Int"},{"key":"R17-17-20210129","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/jat\/bks038","article-title":". DUID: oral fluid and blood confirmation compared in Belgium.","volume":"36","author":"van der Linden","year":"2012","journal-title":"J Anal Toxicol"},{"key":"R18-17-20210129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jchromb.2011.02.027","article-title":". A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry.","volume":"879","author":"Langel","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R19-17-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.forsciint.2007.05.022","article-title":". Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.","volume":"175","author":"Pehrsson","year":"2008","journal-title":"Forensic Sci Int"},{"key":"R20-17-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/scientificamerican1000-82","article-title":"Better decisions through science.","volume":"283","author":"Swets","year":"2000","journal-title":"Sci Am"},{"key":"R21-17-20210129","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis.","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recogn Lett"},{"key":"R22-17-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/32.6.393","article-title":". Drug testing in oral fluid-evaluation of sample collection devices.","volume":"32","author":"Langel","year":"2008","journal-title":"J Anal Toxicol"},{"key":"R23-17-20210129","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2125.2008.03252.x","article-title":". The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam.","volume":"66","author":"Smink","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R24-17-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2125.1980.tb01732.x","article-title":". Comparison of plasma and saliva levels of diazepam.","volume":"10","author":"de Gier","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"R25-17-20210129","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/cpt1978246720","article-title":"Diazepam concentrations in parotid saliva, mixed saliva, and plasma.","volume":"24","author":"DiGregorio","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"R26-17-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0773.1979.tb02354.x","article-title":". Pharmacokinetics of nitrazepam in saliva and serum after a single oral dose.","volume":"45","author":"Kangas","year":"1979","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"R27-17-20210129","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.jchromb.2011.09.002","article-title":". Drugs of abuse in oral fluid collected by two different sample kitsstability testing and validation using ultra performance tandem mass spectrometry analysis.","volume":"879","author":"Lund","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R28-17-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1520\/JFS16081J","article-title":"Stability of nitrobenzodiazepines in postmortem blood.","volume":"43","author":"Robertson","year":"1998","journal-title":"J Forensic Sci"},{"key":"R29-17-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jat\/34.7.420","article-title":". Comparison of ethanol and other drugs of abuse concentrations in whole blood stored in venoject glass and plastic and venosafe plastic evacuated tubes.","volume":"34","author":"Karinen","year":"2010","journal-title":"J Anal Toxicol"},{"key":"R30-17-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.forsciint.2011.04.005","article-title":". Stability of diazepam in blood samples at different storage conditions and in the presence of alcohol.","volume":"215","author":"Atanasov","year":"2012","journal-title":"Forensic Sci Int"},{"key":"R31-17-20210129","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/FTD.0b013e31803d3c04","article-title":"Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results.","volume":"29","author":"Jones","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R33-17-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.forsciint.2004.02.012","article-title":"Preanalytic aspects in postmortem toxicology.","volume":"142","author":"Skopp","year":"2004","journal-title":"Forensic Sci Int"},{"key":"R36-17-20210129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trf.2012.11.004","article-title":". Associations between substance use and fatal road traffic accidents among car and van drivers in Norway: a case-control study.","volume":"17","author":"Gjerde","year":"2013","journal-title":"Transportation Res Part F"},{"key":"R37-17-20210129","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.forsciint.2011.06.024","article-title":"Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: a study of tetrahydrocannabinol and amphetamine.","volume":"212","author":"Gjerde","year":"2011","journal-title":"Forensic Sci Int"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e3182a3ab42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:41:24Z","timestamp":1620952884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201404000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3182a3ab42","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}